LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
89.655 USD
+1.64 (+1.87%)
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LMAT has a decent growth rate and is not valued too expensively. These ratings could make LMAT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
LMAT had a positive operating cash flow in the past year.
Each year in the past 5 years LMAT has been profitable.
Each year in the past 5 years LMAT had a positive operating cash flow.
1.2 Ratios
LMAT's Return On Assets of 8.16% is amongst the best of the industry. LMAT outperforms 92.11% of its industry peers.
LMAT's Return On Equity of 12.99% is amongst the best of the industry. LMAT outperforms 89.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.70%, LMAT belongs to the top of the industry, outperforming 84.74% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 8.88%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
The Profit Margin of LMAT (20.08%) is better than 93.68% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT's Operating Margin of 23.34% is amongst the best of the industry. LMAT outperforms 93.68% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
LMAT has a Gross Margin of 69.11%. This is in the better half of the industry: LMAT outperforms 77.37% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LMAT has been increased compared to 1 year ago.
LMAT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
LMAT has an Altman-Z score of 7.50. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.50, LMAT belongs to the best of the industry, outperforming 85.79% of the companies in the same industry.
LMAT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as LMAT would need 3.21 years to pay back of all of its debts.
LMAT has a Debt to FCF ratio of 3.21. This is amongst the best in the industry. LMAT outperforms 86.32% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
LMAT has a Debt to Equity ratio (0.46) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.5 |
ROIC/WACC0.91
WACC8.47%
2.3 Liquidity
LMAT has a Current Ratio of 13.96. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a better Current ratio (13.96) than 98.42% of its industry peers.
LMAT has a Quick Ratio of 11.74. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a better Quick ratio (11.74) than 95.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 23.35% over the past year.
Measured over the past years, LMAT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.13% on average per year.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 14.11% in the last year.
The Revenue has been growing by 13.41% on average over the past years. This is quite good.
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
3.2 Future
The Earnings Per Share is expected to grow by 9.76% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.67% on average over the next years. This is quite good.
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue Next Year13.86%
Revenue Next 2Y11.04%
Revenue Next 3Y10.92%
Revenue Next 5Y9.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 43.52, the valuation of LMAT can be described as expensive.
68.42% of the companies in the same industry are more expensive than LMAT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (27.69), we can say LMAT is valued expensively.
LMAT is valuated quite expensively with a Price/Forward Earnings ratio of 35.37.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 72.11% of the companies are valued more expensively.
LMAT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.18.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.52 | ||
| Fwd PE | 35.37 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 73.68% of the companies listed in the same industry.
LMAT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 77.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.8 | ||
| EV/EBITDA | 23.88 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 13.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.17
PEG (5Y)2.54
EPS Next 2Y14.31%
EPS Next 3Y13.26%
5. Dividend
5.1 Amount
With a yearly dividend of 0.92%, LMAT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.83, LMAT pays a better dividend. On top of this LMAT pays more dividend than 93.16% of the companies listed in the same industry.
With a Dividend Yield of 0.92, LMAT pays less dividend than the S&P500 average, which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has paid a dividend for at least 10 years, which is a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
NASDAQ:LMAT (10/21/2025, 2:26:31 PM)
89.655
+1.64 (+1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.25%
Inst Owner Change-0.96%
Ins Owners7.8%
Ins Owner Change-9.35%
Market Cap2.03B
Analysts78.82
Price Target106.87 (19.2%)
Short Float %6.07%
Short Ratio6.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)0%
PT rev (3m)0.27%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)5.23%
EPS NY rev (1m)0%
EPS NY rev (3m)6%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.52 | ||
| Fwd PE | 35.37 | ||
| P/S | 8.65 | ||
| P/FCF | 38.8 | ||
| P/OCF | 34.54 | ||
| P/B | 5.6 | ||
| P/tB | 7.7 | ||
| EV/EBITDA | 23.88 |
EPS(TTM)2.06
EY2.3%
EPS(NY)2.53
Fwd EY2.83%
FCF(TTM)2.31
FCFY2.58%
OCF(TTM)2.6
OCFY2.89%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)2.17
PEG (5Y)2.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.5 |
F-Score5
WACC8.47%
ROIC/WACC0.91
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
Revenue Next Year13.86%
Revenue Next 2Y11.04%
Revenue Next 3Y10.92%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year43.57%
EBIT Next 3Y22.42%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%